Literature DB >> 27679520

Patiromer-an Oral Calcium-Loaded Potassium Binder: Kalirrhea with Calciuresis.

Michael Emmett1, Ankit Mehta2.   

Abstract

Entities:  

Keywords:  Calcium; Dietary; Polymers; Potassium; calcium; chronic kidney disease; electrolytes; patiromer; phosphate uptake; potassium channels

Mesh:

Substances:

Year:  2016        PMID: 27679520      PMCID: PMC5053797          DOI: 10.2215/CJN.08910816

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  7 in total

1.  Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.

Authors:  George L Bakris; Bertram Pitt; Matthew R Weir; Mason W Freeman; Martha R Mayo; Dahlia Garza; Yuri Stasiv; Rezi Zawadzki; Lance Berman; David A Bushinsky
Journal:  JAMA       Date:  2015-07-14       Impact factor: 56.272

2.  Effect of Patiromer on Urinary Ion Excretion in Healthy Adults.

Authors:  David A Bushinsky; David M Spiegel; Coleman Gross; Wade W Benton; Jeanene Fogli; Kathleen M Hill Gallant; Charles Du Mond; Geoffrey A Block; Matthew R Weir; Bertram Pitt
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-27       Impact factor: 8.237

3.  Effect of the time of administration of calcium acetate on phosphorus binding.

Authors:  L R Schiller; C A Santa Ana; M S Sheikh; M Emmett; J S Fordtran
Journal:  N Engl J Med       Date:  1989-04-27       Impact factor: 91.245

Review 4.  Gastrointestinal adverse events with sodium polystyrene sulfonate (Kayexalate) use: a systematic review.

Authors:  Ziv Harel; Shai Harel; Prakesh S Shah; Ron Wald; Jeffrey Perl; Chaim M Bell
Journal:  Am J Med       Date:  2013-01-12       Impact factor: 4.965

5.  Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease.

Authors:  C Gruy-Kapral; M Emmett; C A Santa Ana; J L Porter; J S Fordtran; K D Fine
Journal:  J Am Soc Nephrol       Date:  1998-10       Impact factor: 10.121

Review 6.  Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.

Authors:  Sophie A Jamal; Ben Vandermeer; Paolo Raggi; David C Mendelssohn; Trish Chatterley; Marlene Dorgan; Charmaine E Lok; David Fitchett; Ross T Tsuyuki
Journal:  Lancet       Date:  2013-07-19       Impact factor: 79.321

Review 7.  Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Leena Patel; Lisa M Bernard; Grahame J Elder
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-14       Impact factor: 8.237

  7 in total
  3 in total

Review 1.  Hyperkalemia in the Hypertensive Patient.

Authors:  Jay Ian Lakkis; Matthew R Weir
Journal:  Curr Cardiol Rep       Date:  2018-03-01       Impact factor: 2.931

2.  Patiromer Acetate Induced Hypercalcemia: An Unreported Adverse Effect.

Authors:  Shreeyukta Bhattarai; Stephen Pupillo; Gulshan Man Singh Dangol; Erdal Sarac
Journal:  Case Rep Nephrol       Date:  2019-02-04

3.  Case report: Patiromer-induced hypercalcemia.

Authors:  Michael R Wiederkehr; Ankit N Mehta; Michael Emmett
Journal:  Clin Nephrol Case Stud       Date:  2019-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.